达芬奇机器人辅助腹膜后腹腔镜肾上腺切除术

目的探讨达芬奇机器人辅助腹膜后腹腔镜肾上腺切除术（RARA）的安全性与可行性。 方法2016年3月至2017年3月，我科以腹膜后途径行RARA患者26例，并与同时期内的经腹腔途径达芬奇机器人辅助肾上腺切除术（RATA）46例，以及常规腹膜后腹腔镜肾上腺切除术（RLA）122例的手术时间（OT）、失血量（EBL）、住院天数（HS）、恢复进食时间（TRFI）进行比较。 结果三组患者术前一般资料差异无统计学意义。RARA的手术时间（45±6）min，失血量（26±5）ml，住院天数（3.6±0.8）d与RATA[（53±4）min、（22±3）ml、（3.5±1.3）d]及RLA[（43±3）min、（26±3）ml、（2.9±0.5）d]间差异均无统计学意义（P>0.05），但在术后早期进食方面表现优于RATA[（18.8±2.2）h vs （24.8±4.7）h，P=0.036]。 结论RARA是一种安全可行的手术方式，有利于患者术后早期肠道功能恢复。

Da Vinci robot assisted retroperitoneal laparoscopic adrenalectomy

ObjectiveTo explore the safety and feasibility of Da Vinci robot assisted retroperitoneal laparoscopic adrenalectomy (RARA). MethodsTwenty-six patients who underwent RARA with retroperitoneal approach, 46 patients who underwent Da Vinci robot assisted transperitoneal adrenalectomy (RATA) and 122 patients who underwent conventional retroperitoneal laparoscopic adrenalectomy (RLA) in the same period in our department from March 2016 to March 2017 were selected. Their operation time (OT), estimated blood loss (EBL), hospital stay (HS) and time to recover food intake (TRFI) were compared. ResultsThe preoperative general data presented no statistically significant difference between three groups. The operation time (45±6) min, estimated blood loss (26±5) ml and hospital stay (3.6±0.8) d of RARA had no statistically significant difference (P>0.05) compared with those of RATA [(53±4) min, (22+3) ml, (3.5±1.3) d] and RLA [(43±3) min, (26±3) ml, (2.9±0.5) d], but the early postoperative food intake was better than that of RATA [(18.8±2.2) h vs (24.8±4.7) h, P=0.036]. ConclusionRARA is safe and feasible, which is beneficial to the early postoperative recovery of intestinal function.